ResearchSafe

Dihexa (Dihexa (N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide))

Category: Cognitive & Nootropic. Status: Research compound.

An angiotensin IV analog reported 10 million times more potent than BDNF at enhancing synaptic connectivity. Promotes synaptogenesis and spinogenesis.

How it works

Allosteric potentiator of HGF/c-Met signaling driving synaptogenesis, dendritic spine formation, and neuronal survival in hippocampal circuits.

Key facts

  • Molecular weight: 507.6 Da
  • Half-life: 6-12 hours
  • Bioavailability: Moderate (oral/SubQ)
  • Storage: Room temperature (capsule). Solution: -20°C.

Dosing overview

  • Typical dose: 10-20 mg (oral) or 2-5 mg (SubQ)
  • Frequency: Daily
  • Duration: 4-8 weeks
  • Route: Oral or Subcutaneous

Reported benefits

  • Dramatic synaptogenesis
  • Memory improvement
  • Cognitive restoration potential
  • Dendritic spine growth
  • HGF/c-Met activation

Possible side effects

  • Limited safety data
  • Theoretical cancer concern (c-Met)
  • Headache
  • Overstimulation

Research

  • Dihexa as cognitive enhancer via HGF/c-Met (2019): Restored scopolamine-impaired memory at picomolar concentrations through hippocampal synaptogenesis.
  • Angiotensin IV analogs augment hippocampal connectivity (2018): Increased functional synaptic connections by 300% through c-Met dependent spinogenesis.

Compare Dihexa

Community discussions about Dihexa

Research and educational reference only. Not medical advice.